Cardiac fibroblasts (CF) play a central role in the repair and remodeling of the heart following injury and are important regulators of inflammation and extracellular matrix (ECM) turnover. ECM-regulatory matricellular proteins are synthesized by several myocardial cell types including CF. We investigated the effects of pro-inflammatory cytokines on matricellular protein expression in cultured human CF. cDNA array analysis of matricellular proteins revealed that interleukin-1 (IL-1, 10 ng/ml, 6 h) down-regulated connective tissue growth factor (CTGF/CCN2) mRNA by 80% and up-regulated tenascin-C (TNC) mRNA levels by 10-fold in human CF, without affecting expression of thrombospondins 1-3, osteonectin or osteopontin. Western blotting confirmed these changes at the protein level. In contrast, tumor necrosis factor  (TNF) did not modulate CCN2 expression and had only a modest stimulatory effect on TNC levels. Signaling pathway inhibitor studies suggested an important role for the p38 MAPK pathway in suppressing CCN2 expression in response to IL-1. In contrast, multiple signaling pathways (p38, JNK, PI3K/Akt and NFB) contributed to IL-1-induced TNC expression. In conclusion, IL-1 reduced CCN2 expression and increased TNC expression in human CF. These observations are of potential value for understanding how inflammation and ECM regulation are linked at the level of the CF.
Introduction
The acute inflammatory response observed following myocardial infarction (MI) 1 plays an integral role in tissue repair and the heart's adaptation to injury (Nian et al., 2004; Frangogiannis et al., 2002) . However, inflammatory mediators can also be detrimental and promote adverse cardiac remodeling and heart failure progression (Nian et al., 2004) . The pro-inflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor  (TNF) are two key players in the myocardial inflammatory response to injury. The inflammatory cells that infiltrate the infarct zone are the predominant source of these cytokines in the early stages following MI, however in the longer-term pro-inflammatory cytokines may be produced by myocardial cells at sites remote from the initial injury (Irwin et al., 1999; Deten et al., 2002) .
In addition to hematopoietic cells, cardiomyocytes and fibroblasts (the two major resident cell types of the heart) have the capacity to secrete TNF, and fibroblasts appear to be the main source of IL-1 (Jugdutt, 2003; Long, 2001) . In turn these cytokines can have profound effects on the pathophysiology of cardiac myocytes and fibroblasts. Cardiomyocytes undergo apoptosis and/or hypertrophy in response to many pro-inflammatory cytokines, whilst fibroblasts adopt a myofibroblast phenotype and undergo increased proliferation and collagen turnover and thereby contribute to adverse post-MI remodeling Jugdutt, 2003) . IL-1 and TNF have each been shown to induce distinct patterns of extracellular matrix (ECM) protein and/or protease expression in the heart that contribute to adverse remodeling in heart failure (Bradham et al., 2002; Turner et al., 2010; Turner and Porter, 2012) .
The matricellular proteins are a group of ECM proteins that are synthesized by a number of different cell types including fibroblasts, macrophages and endothelial cells 1 Abbreviations: CF, cardiac fibroblast; CCN2/CTGF, connective tissue growth factor; ECM, extracellular matrix; HK, housekeeping gene; IL-1, interleukin-1; MI, myocardial infarction; TGF, transforming growth factor beta; TNC, tenascin-C; TNF, tumor necrosis factor. (Frangogiannis, 2012) . However, unlike structural matrix proteins, they do not play a principal role in tissue architecture, but serve as biological mediators of cell function by interacting with cells directly or by modulating the activity of cytokines, growth factors, proteases and other ECM proteins (Frangogiannis, 2012) . Matricellular proteins can regulate cell movement, proliferation and differentiation during morphogenesis and the inflammatory and reparative response following tissue injury. The expanding family of matricellular proteins includes the thrombospondins (THBS 1-5), the CCN family (most notably CCN2; also known as connective tissue growth factor, CTGF), osteonectin (SPARC), osteopontin (SPP1), tenascin-C (TNC), tenascin-X, periostin and galectin (Frangogiannis, 2012) .
Most matricellular proteins show increased expression in the heart following MI or stress where they act as transducers of key molecular signals in cardiac repair and as modulators of cell migration, proliferation and adhesion (Frangogiannis, 2012) . Hence they play a vital function in tissue repair and post-MI remodeling. There is however, increasing evidence to suggest that the matricellular proteins may also modulate the inflammatory and fibrotic process in myocardial remodeling, which leads to cardiac dysfunction and heart failure (Dobaczewski et al., 2010; Okamoto and Imanaka-Yoshida, 2012; Schellings et al., 2004) .
The aims of the present study were to determine whether IL-1 and TNF could modulate expression of matricellular proteins in human cardiac fibroblasts (CF) and to identify the intracellular signaling pathways responsible for these effects.
Results

Myofibroblast phenotype
Human CF spontaneously adopted a myofibroblast phenotype when cultured in vitro, as defined by co-expression of -smooth muscle actin and vimentin (data not shown), in agreement with our previous reports (Porter et al., 2004b; Turner et al., 2003; Mughal et al., 2009 ). Such a phenotypic transition bears similarities to that observed when CF differentiate to myofibroblasts in vivo (Santiago et al., 2010) and so our findings with cultured human CF are particularly relevant to myofibroblast function in the remodeling heart.
Effect of IL-1 on mRNA expression of matricellular proteins in human CF
CF were stimulated with 10 ng/ml IL-1 for 6 h before extracting RNA and measuring mRNA levels of seven matricellular proteins as part of a focused RT-PCR array (Table 1) .
Although the array did not include all the known members of the matricellular protein family, it did facilitate evaluation of the most well-studied members. Unstimulated cells expressed particularly high basal mRNA levels of THBS1, SPARC (osteonectin) and CTGF/CCN2, and appreciable levels of THBS2. Basal TNC and THBS3 mRNA levels were relatively low, and SPP1 (osteopontin) levels were below the threshold of detection. IL-1 treatment had opposing effects on CCN2 and TNC expression; it decreased CCN2 expression by 80% and increased TNC expression by almost 10-fold (Table 1) . mRNA expression levels of the other matricellular proteins were not markedly altered in response to IL-1 treatment (Table 1) .
Opposing effects of IL-1 on CCN2 and TNC expression
Additional experiments were performed to confirm the array results for CCN2 and TNC. CF from 3 different patients were stimulated with IL-1, RNA extracted over a 2-24 h time course, and CCN2 and TNC mRNA levels determined by real-time RT-PCR with Taqman primer/probes sets. In agreement with the 6 h array data, IL-1 potently reduced CCN2 mRNA levels, and this reduction of up to 80% was maintained over the full 2-24 h time course (Fig. 1A) . TNC mRNA levels were increased over the same time period, with peak expression (10-fold increase) observed 4 h after IL-1 treatment, and levels remaining elevated by 7-fold even 24 h after IL-1 stimulation (Fig. 1B) .
Western blotting studies confirmed robust basal expression of CCN2 protein by human CF that was rapidly suppressed by IL-1 (Fig. 1C) . CCN2 protein levels were decreased by 80% within 4 h of IL-1 treatment, and remained low for at least 24 h (Fig. 1C) . CCN2
resolved as a doublet of 35-40 kDa, in agreement with previous studies (Abraham et al., 2000) . Western blotting also revealed that IL-1 stimulated protein expression of TNC, which was elevated 3.2-fold within 6 h and continued to rise to a 10-fold induction by 24 h (Fig. 1D) . TNC resolved as a doublet of >250 kDa, in agreement with previous studies (Nakoshi et al., 2008) .
Comparison of effects of IL-1 and TNF
We have previously shown that TNF is another important proinflammatory cytokine that can induce human CF migration, proliferation and altered gene expression (Porter et al., 2004a; Turner et al., 2007; Turner et al., 2011) . We therefore compared the effects of TNF (10 ng/ml, 6 h) with those of IL-1 (10 ng/ml, 6 h) on CCN2 and TNC mRNA and protein expression in a side-by-side manner. In stark contrast to the 70-80% inhibition in CCN2 mRNA and protein observed with IL-1, TNF treatment had no significant effect on CCN2 mRNA ( Fig. 2A) or protein (Fig. 2C ) levels. In contrast, TNF increased TNC mRNA levels by 2.6-fold (Fig. 2B) , and appeared to induce TNC protein expression slightly (Fig. 2D ), although this was not statistically significant and was much less than the response to IL-1.
Signaling pathways mediating the effects of IL-1 on CCN2 and TNC expression
IL-1 rapidly stimulates several intracellular signaling pathways in human CF, including ERK, p38 MAPK, JNK, PI3K/Akt and NFB . To determine which of these pathways were responsible for directly mediating the effects of IL-1 on CCN2 and TNC expression, we pretreated cells with selective pharmacological inhibitors (PD98059, SB203580, SP600125, LY294002 and IMD-0354 respectively) before stimulating cells with IL-1 and measuring mRNA levels after 2 h or protein levels after 6 h ( Fig. 3 and 4) . These relatively early time points were selected to evaluate direct roles of the signaling pathways on gene expression, rather than any contribution via autocrine/paracrine signaling mechanisms.
Inhibitors were used at concentrations that we have previously shown to effectively and selectively inhibit relevant pathways in this cell type (Turner et al., 2007) .
The IL-1-mediated decrease in CCN2 expression at both mRNA ( Fig. 3A) and protein ( Fig. 3B ) levels was attenuated by the p38 MAPK inhibitor SB203580, suggesting an important role for p38 MAPK in mediating the inhibitory effects of IL-1. None of the other inhibitors specifically affected the ability of IL-1 to reduce CCN2 mRNA expression, although SP600125, LY294002 and IMD-0354 did increase basal CCN2 mRNA levels ( Fig.   3A ). The NFB pathway inhibitor IMD-0354 overcame the suppressive effect of IL-1 on CCN2 expression at the protein level, resulting in elevated CCN2 levels relative to control cells ( Fig. 3B ). However, this may have been due to an effect on basal expression, as IMD-0354 alone induced a doubling of CCN2 mRNA levels in the absence of IL-1 (Fig. 3A) .
The IL-1-induced increase in TNC mRNA expression was partially attenuated by inhibitors of p38 MAPK, JNK, PI3K/Akt and NFB pathways, but not the ERK pathway inhibitor PD98059 (Fig. 4A ). PD98059 was similarly ineffective in modulating IL-1-induced TNC protein levels, whereas the other inhibitors partially reduced TNC protein levels, with the NFB pathway inhibitor IMD-0354 being most effective (60% inhibition) (Fig. 4B ).
Discussion
The key finding of our study was that IL-1 simultaneously down-regulated CCN2 and up-regulated TNC expression in human CF, without affecting expression of several other matricellular proteins. The TNC response to IL-1 was reproducibly higher than that induced by TNF, whereas TNF had no significant effect on CCN2 expression in these cells.
Signaling inhibitor studies suggested an important role for the p38 MAPK pathway in IL-1-mediated suppression of CCN2 levels, whereas a combination of several pathways (p38, JNK, PI3K/Akt and NFB) contributed to IL-1-induced TNC expression.
It is clear that the matricellular proteins play important roles in cardiac pathophysiology (Schellings et al., 2004; Frangogiannis, 2012) . These molecules are minimally expressed in the healthy adult heart but are markedly upregulated in the injured and remodeling myocardium, where they regulate inflammatory, reparative, fibrotic and angiogenic processes. THBS1 is expressed in the early stages following MI and serves to limit the expansion of the inflammatory phase of infarct healing and so attenuates the spread of damage to the non-infarcted myocardium (Frangogiannis et al., 2005) . In contrast, CCN2, TNC, SPARC and SPP1 are primarily expressed during the granulation and scar formation stages and are important for myofibroblast recruitment, collagen deposition and fiber assembly (Komatsubara et al., 2003; Tamaoki et al., 2005; Dobaczewski et al., 2006; Trueblood et al., 2001; Daniels et al., 2009; McCurdy et al., 2011) .
In the present study, we were able to detect mRNA expression of THBS1-3, SPARC, CCN2 and TNC mRNA in human CMF, but SPP1 mRNA was not detectable. The high basal levels of expression of these matricellular proteins was likely due to the activated myofibroblast phenotype observed when human CF are grown in culture. Marked changes in mRNA expression were observed for CCN2 (decrease) and TNC (increase) following stimulation with IL-1 and the importance of these findings is discussed below.
CCN2
CCN2 levels are elevated in various fibrotic disorders and it is reported to be an excellent surrogate marker for activated fibroblasts in wound healing and fibrosis (Daniels et al., 2009; Leask et al., 2009) . CCN2 is strongly induced by transforming growth factor  (TGF) in human dermal fibroblasts (Leask et al., 2003) and there is evidence to suggest that CCN2 is a cofactor required to enhance the fibrotic response to TGF (Kennedy et al., 2007; Shi-wen et al., 2006) . More recently a direct profibrotic effect of CCN2 (through the transcriptional activation of the collagen I 2 gene) was demonstrated in murine lung fibroblasts (Ponticos et al., 2009) , and the loss of CCN2 was shown to provide resistance to bleomycin-induced skin fibrosis (Liu et al., 2011) . On the basis of these profibrotic effects, it could be predicted that a down regulation of CCN2 by IL-1 may act to suppress profibrotic mechanisms during the inflammatory phase of post-MI remodeling (van Nieuwenhoven and Turner, 2013) .
A recent transgenic study using cardiac-restricted overexpression of CCN2 demonstrated that rather than restricting cardiac function, as might be expected, CCN2 was found to elicit a number of cardioprotective effects, notably the induction of myocardial genes known to be involved in the regulation of cardiac growth and cardioprotection (Ahmed et al., 2011; Gravning et al., 2012) . Moreover, mice with this transgene displayed remarkable resistance to dilated cardiomyopathy and heart failure and were protected against ischemia/reperfusion injury (Ahmed et al., 2011; Gravning et al., 2012) .
Previous studies in fibroblasts of non-cardiac origin have determined that CCN2 expression can be stimulated by profibrotic molecules such as TGFβ or angiotensin II, and inhibited by proinflammatory molecules such as IL-1 or TNF. For example, TGFβ-induced CCN2 expression was inhibited by TNF (Abraham et al., 2000; Beddy et al., 2006; Lin et al., 1998) or IL-1 (Nowinski et al., 2002; Nowinski et al., 2010) in human dermal fibroblasts or fibroblasts from bowel biopsies. In human dermal fibroblasts, IL-1 reduced TGFβ-induced CCN2 transcription via inhibitory effects on Smad3 (Nowinski et al., 2010) , whereas in mouse embryonic fibroblasts stimulated with TNF a role for Smad4 was proposed (Yu et al., 2009 ). Although we observed a consistent reduction in CCN2 expression following IL-1 treatment in human CF, no reduction was observed with TNF. We have previously reported that TNF responses in human CF are variable between cells from different patients (Porter et al., 2004a) . However this observation is unlikely to explain the lack of effect on CCN2 expression, as TNC mRNA levels were elevated by TNF treatment in identical samples. Other groups have also reported that TNF does not inhibit basal CCN2 expression in fibroblasts from non-cardiac sources, but can inhibit the TGFβ-induced increment in CCN2 expression (Abraham et al., 2000; Beddy et al., 2006; Yu et al., 2009 ).
CCN2 gene transcription is known to be positively or negatively influenced by a range of stimuli in different cell types (Daniels et al., 2009; Leask et al., 2009) . Positive regulatory signals including TGF, angiotensin II, endothelin-1 and mechanical stretch can induce CCN2 gene expression through activation of Smads, protein kinase C, ERK and RhoA signaling pathways (Daniels et al., 2009; Leask et al., 2009) . In contrast, inhibitors of CCN2 gene transcription appear to act via the NFB, cyclic AMP, cyclic GMP and PPAR signaling pathways (Daniels et al., 2009; Leask et al., 2009) . Our data revealed that IL-1 strongly attenuated the high basal CCN2 expression in human CF at both mRNA and protein levels, and that this could be overcome by selective inhibition of the p38 MAPK pathway.
The p38 MAPK pathway is an important signaling axis regulating CF function and represents an attractive therapeutic target for ameliorating cardiac dysfunction post-MI (Turner, 2011).
Given that SB203580 inhibits the  and  subtypes of p38, but not p38- or - (Clark et al., 2007) , and our previously observation that human CF express the ,  and  subtypes of p38, but not p38- (Sinfield et al., 2013), our data most likely indicate a role for p38- in the IL-1-mediated inhibition of CCN2 expression in this cell type. remodeling and poor prognosis, supporting the view that excessive and sustained increments of TNC could lead to detrimental myocardial remodeling (Sato et al., 2006) .
Our data revealed that IL-1 strongly induced TNC expression in human CF, and that this could be partially reduced by inhibitors of the p38, JNK, PI3K/Akt and NFB pathways, with the NFB inhibitor being most potent. A recent study investigating the effects of IL-1β on TNC expression in synovial fibroblasts reported an upregulation of TNC expression, but only under hypoxic conditions (Tojyo et al., 2008) . Although little is known regarding the mechanisms underlying transcription of the human TNC gene, there is accumulating evidence that the NFB pathway is pivotal (Nakoshi et al., 2008; Goh et al., 2010) . In a study on cultured human chondrocytes, NFB inhibition was found to prevent TNF-induced TNC mRNA and protein expression (Nakoshi et al., 2008) . Moreover, in human monocyte-derived dendritic cells, lipopolysaccharide was shown to induce TNC expression via activation of the NFB and PI3K/Akt pathways, but not the p38, JNK or ERK pathways (Goh et al., 2010) .
The authors identified numerous putative NFB-binding sites within the promoter and first intron of the human TNC gene promoter that potentially mediate the stimulatory effect of lipopolysaccharide and other proinflammatory molecules (Goh et al., 2010) . The induction of TNC in neonatal rat cardiac myocytes subjected to mechanical deformation also involved the activation of NFB, but occurred independently of PKC and MAPK activation (Yamamoto et al., 1999) . Our data provide the first insight into regulation of TNC expression in human CF, and support a key role for NFB and PI3K/Akt pathways as well as the stress-activated kinases p38 and JNK.
Conclusion
We have demonstrated that the proinflammatory cytokine IL-1 has opposing effects on expression of CCN2 and TNC in human CF, whilst TNF has little or no effect. IL-1-mediated inhibition of CCN2 expression occurred via a p38-dependent pathway and may act to suppress profibrotic mechanisms during the inflammatory phase of post-MI remodeling.
Moreover, IL-1-induced upregulation of TNC may aid myofibroblast recruitment and drive early myocardial repair mechanisms following MI.
Experimental Procedures
Reagents
Recombinant human IL-1 and TNF were purchased from Invitrogen. IMD-0354, PD98059, SB203580 and SP600125 were purchased from Calbiochem (Nottingham, UK) and LY294002 was from Alexis Biochemicals (Nottingham, UK).
Cell culture
Right atrial appendage biopsies from multiple patients undergoing elective coronary artery bypass surgery at the Leeds General Infirmary were obtained following local ethical committee approval and informed patient consent. Primary cultures of CF were harvested, cultured and characterized as >99% pure population of -smooth muscle actin and vimentin co-expressing cells (i.e. myofibroblasts), as we have described previously (Porter et al., 2004b; Turner et al., 2003; Mughal et al., 2009) . Experiments were performed on early passage cells (P3-P5) from several different patients (indicated by n number). Cells were cultured under serum-free conditions for 48 h before performing experiments in medium supplemented with 0.4% fetal calf serum.
RT-PCR Array
Cells from 3 different patients were treated with or without 10 ng/ml IL-1 for 6 h before extracting RNA using the Aurum Total RNA kit (BioRad). Equivalent RNA samples from each of the 3 patients were pooled before preparing cDNA and measuring expression levels of matricellular proteins as part of a SYBR Green-based real-time PCR array (RT 2 Profiler
Human Extracellular Matrix and Adhesion Molecules, SABiosciences, Qiagen), as we described previously (Turner et al., 2010; Turner et al., 2011) . ∆C T values for the target genes were calculated by subtracting the mean C T value (threshold cycle number) of the 5 housekeeping (HK) genes on the array (β2-microglobulin, hypoxanthine phosphoribosyltransferase 1, ribosomal protein L13A,β-actin and glyceraldehyde-3-phosphate dehydrogenase [GAPDH] ) from the C T value of the target genes. Data are expressed as a percentage of the mean of HK genes using the formula 2 -∆C T x100.
Real-time RT-PCR
RNA was extracted from cells (Aurum Total RNA kit) following appropriate treatments.
Real-time RT-PCR was performed using intron-spanning human CCN2/CTGF (Hs00170014_m1) and TNC (Hs01115665_m1) primers and Taqman probes (Applied Biosystems). Data are expressed as percentage of GAPDH endogenous control mRNA expression (Hs99999905_m1 primers) using the formula 2 -∆CT x 100.
Western Blotting
Protein homogenates were prepared by directly scraping cell layers into sample buffer, and equal amounts of protein (typically 30 µg/lane) were resolved by SDS-PAGE before immunoblotting as described previously (Turner et al., 2001) . Western blotting was performed using 1:1000 diluted goat polyclonal anti-CCN2 antibody (sc-14939, Santa Cruz Biotechnology) or 1:1000 diluted rabbit polyclonal anti-human TNC antibody (sc-20932, Santa Cruz Biotechnology), and immunolabelled proteins detected and densitometry quantified as described previously (Turner et al., 2001 ). Equal protein loading was confirmed with 1:7500 diluted mouse anti--actin monoclonal antibody (ab8226, Abcam).
Statistical analysis
Results are mean ± SEM with n representing the number of experiments on cells from different patients. Data were analyzed as ratios using repeated measures one-way ANOVA -actin -37
